par Dethy, Sophie ;Van Blercom, Nadège ;Damhaut, Philippe;Wikler, David ;Hildebrand, Jerzy ;Goldman, Serge
Référence Movement disorders, 13, 2, page (275-280)
Publication Publié, 1998-03
Référence Movement disorders, 13, 2, page (275-280)
Publication Publié, 1998-03
Article révisé par les pairs
Titre: |
|
Auteur: | Dethy, Sophie; Van Blercom, Nadège; Damhaut, Philippe; Wikler, David; Hildebrand, Jerzy; Goldman, Serge |
Informations sur la publication: | Movement disorders, 13, 2, page (275-280) |
Statut de publication: | Publié, 1998-03 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Basal ganglia |
Fluorodeoxyglucose | |
Parkinson's disease | |
Positron emission tomography | |
Striatonigral degeneration | |
MeSH keywords: | Adult |
Aged | |
Antiparkinson Agents -- adverse effects | |
Antiparkinson Agents -- therapeutic use | |
Basal Ganglia -- drug effects | |
Basal Ganglia -- radionuclide imaging | |
Blood Glucose -- metabolism | |
Brain Mapping | |
Dominance, Cerebral -- drug effects | |
Dominance, Cerebral -- physiology | |
Energy Metabolism -- drug effects | |
Energy Metabolism -- physiology | |
Female | |
Fluorodeoxyglucose F18 -- diagnostic use | |
Fluorodeoxyglucose F18 -- metabolism | |
Humans | |
Levodopa -- adverse effects | |
Levodopa -- therapeutic use | |
Male | |
Middle Aged | |
Motor Skills -- drug effects | |
Motor Skills -- physiology | |
Multiple System Atrophy -- drug therapy | |
Multiple System Atrophy -- radionuclide imaging | |
Neurologic Examination -- drug effects | |
Parkinson Disease -- drug therapy | |
Parkinson Disease -- radionuclide imaging | |
Tomography, Emission-Computed | |
Treatment Outcome | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0885-3185 |
info:doi/10.1002/mds.870130213 | |
info:scp/0031906152 | |
info:pmid/9539341 |